As expected, women with a second breast cancer were older than women with a first breast cancer for both estrogen receptor–positive cancers (65 vs 59.7 years of age) and estrogen receptor–negative cancers (56.8 vs 53.2 years of age). This evidence concerns the gene ESR1 and breast carcinoma.